will i still be able to get compounded semaglutide Injection: GLP-1 weight loss, prescribed online Despite FDA ruling, compounded GLP-1s

abstract 148:A14259 Neumann J, Hofmann B, Dhein S, Gergs U (2023b) Glucagon and its receptors in the mammalian heart

That fiscal backdrop helps explain why most public plans have so far limited GLP1 coverage to diabetes, even as evidence for weightloss and cardiometabolic benefits in people with obesity has grown

For now, patients are left navigating an increasingly complicated path with limited guidance about how to access these life-saving treatments.

When they work, these pricey drugs can help reduce the risk for diabetes (and help manage it), heart disease, stroke and kidney disease, among other conditions

These effects could potentially shield the brain from the damaging effect of the disorder, leading to better long-term outcomes for patients